# Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.

> **NCT04370015** · NA · UNKNOWN · sponsor: **Services Institute of Medical Sciences, Pakistan** · enrollment: 374 (estimated)

## Conditions studied

- SARS-CoV-2
- Healthcare Workers

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04370015
- **Lead sponsor:** Services Institute of Medical Sciences, Pakistan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-15
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-10-15
- **Target enrollment:** 374 (ESTIMATED)
- **Last updated:** 2020-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04370015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04370015, "Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04370015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*